| Key Speakers
• Samir K.Bhattacharyya, Senior Director Global Marketing Home Hemodialysis Therapy, Baxter Healthcare
• Alina Ciobanu, Manager, Health Economics & Patient Access, Astrazeneca
• Dr. Elyce A. Biddle, Senior Research Economist, National Institute for Occupational Safety and Health, U.S Govt.
• Robert Humenick, Head Pricing and Reimbursement, Wyeth Pharmaceuticals
• Dee Woodhull, CIH, CSP Senior Consultant, ORC Worldwide
• Dr. Kevin W. Mayo, Vice President, Bridgehead International, Professor, University of the Sciences in Philadelphia
• Dr. Nick Poulios, VP-Pricing & Reimbursement Strategy, Patient Access & Public Policy, Elan Pharmaceuticals
• Todd Evans, Director, Pricewaterhouse Coopers
• Dr. Eugene Mick Kolassa, Chairman, Medical Marketing Economics, LLC
• W. Neil Palmer, Vice President, Pricing & Reimbursement, RTI Health Solutions
• Christian Schuler, Partner, Simon-Kucher & Partners
• Senior Principal, Pricing & Market Access, IMS Consulting
• William Haddad, CEO, Biogenerics
• George Wyatt, Managing Director, Wyatt Health Management
• Sanjay Bajpai, President, Institute of Pharmaceutical Management
• Cyrus Chowdhury, Management Consultant, Insight
Pharmaceutical companies are facing challenges in the present economic climate. An effective pricing strategy is vital in implementation of assessments of cost effectiveness. Visiongain's 8th Annual Pricing and Reimbursement conference is aimed at providing you with the opportunity to gain an understanding of the healthcare market dynamics and P&R environment and create an effective price policy. This 2 day event will help you achieve competitive advantage in current pricing and reimbursement environment. Why Attend?
• Share and discuss the key global pricing and reimbursement approaches
• Learn about the current global pharmaceutical market
• Analyse the future pricing trends in US
• Gain insight into the role of health economics in pricing
• Design innovative P&R strategies for biopharmaceuticals
• Stay up-to-date on the latest innovations in pricing and reimbursement
• Seize this opportunity to network with leaders from pharma-biotech, healthcare and regulatory agencies
• Make the most profitable decisions Who should attend?
VPs, Directors, Heads and Managers of:
• Pricing and Reimbursement
• Strategic Pricing
• Price Monitoring
• Reimbursement & Market Access
• Research and Development
• Health Economics
• Commercial Pricing
• Economics and Government Affairs
• International Trade and Market Policy
• Parallel Trade
• Business Strategy
• Sales & Marketing
• Corporate Strategy
• Regulatory Affairs
• Outcomes Research
• Contracts
• Legal
• Health Policy Advisors Location Sheraton University City Hotel Surrounded by Philadelphia's famed education and medical centres, the Sheraton Philadelphia University City Hotel is a great choice when visiting Philadelphia for business or leisure. Conveniently located on the campus of the University of Pennsylvania, they are just steps away from Drexel University, Amtrak's 30th Street Station, and the three hospitals of the University of Pennsylvania Health System. Plus, the convention and historical districts of Centre City Philadelphia and the Philadelphia Zoo are just minutes away. Each of their 332 guest rooms are designed to ensure your comfort. Stay connected with the full-service desktop computer in the room, which provides complimentary Internet access. Complimentary wireless Internet access is available in all guest rooms and in the main lobby. The Sheraton boasts 10,000 square feet of flexible meeting space, all supported by a full-service business centre. Guests can enjoy thoughtful touches like an onsite gift shop, florist, and Enterprise Car Rental. Work out with state of the art equipment at their newly remodelled Fitness Centre, featuring an outdoor seasonal pool and skyline views of the University of Pennsylvania and University City. Complimentary 24-hour access is given to all overnight guests. www.philadelphiasheraton.com
3549 Chestnut St
Philadelphia, PA 19104, United States
+1 877-459-1156
Pricing
Conference only £1299 GBP Promotional Literature Distribution Distribution of your company's promotional literature to all conference attendees £999 GBP
Special discounts are available for non profit organisations and academics, please contact me for details.
Booking
Ordering is simple! All you need to do to book your place at this conference is contact Arpan and I will guide you through the process. Please ask for travel and accommodation options. You can either call me on TEL: +44 (0)207 549 9939 or email mailto:arpan.desai@vg-sales.com Alternatively, you can find all the details you need on how to order at the end of this email. Please feel free to contact me should you have any questions, I look forward to hearing from you. King Regards, Arpan Desai
Schedule
Day 1 Day 1, Thursday 11th June 2009 09:30 Registration and refreshments 10:00 Opening address from the chair Dr. Eugene Mick Kolassa
Chairman
Medical Marketing Economics, LLC 10:10 Identifying and overcoming the limitations of current approaches to pharmaceutical pricing
• Why basic economic assumptions and models don't apply to pharmaceutical markets
• Why many pricing research approaches either ask the wrong questions or lead respondents to the wrong answers
• Why failure to develop true pricing strategies always leaves money on the table
• Why a lack of policies leads to bad pricing
• Why failing to understand value is the number one pricing mistake
• How to bring some pricing discipline and pricing power to your firms Dr. Eugene Mick Kolassa
Chairman
Medical Marketing Economics, LLC 10:50 How to develop an effective pricing and reimbursement strategy?
• What is an effective strategy? What should the goals be for any strategy?
• The development process and how to maximise value from the outset: the lessons of strategic pricing assessments
• How to stand out from the crowd and develop genuinely innovative P&R strategies Sanjay Bajpai
President
Institute of Pharmaceutical Management 11:30 Morning refreshments 11:50 Latest innovations in pricing and reimbursement
• Assessing approaches to innovation in the realm of P&R
• The importance of price optimization and individually tailored pricing
• Innovative pricing strategies Robert Humenick
Head Pricing and Reimbursement
Wyeth Pharmaceuticals 12:30 The future of strategic pricing for pharma
Changing business landscape, future of pricing and strategic opportunities for the pharmaceutical industry
Exploring how the industry's approach to sales and marketing will change as it moves towards providing a range of new products and services to the market
Addressing the relationship of value based benefits, outcomes and comparative effectiveness to future pricing strategies Todd Evans
Director
PricewaterhouseCoopers 13:10 Networking lunch 14:30 Assessment of EU market growth of private healthcare vs public
• Where is the trend line heading? Are traditional levels of public healthcare provision sustainable?
• What is the landscape for private healthcare provision in Europe?
• Increasing private provision of healthcare will involve addressing traditional ideological concerns, making private healthcare more attractive and driving accountability of public healthcare providers 15:10 Comparing the European/US/Canada P&R and HE&OR systems
• What are the similarities between the systems and is there a trend to harmonization?
• What are the crucial differences and which system is most effective?
• What are the implications of developing trends in different P&R systems? W. Neil Palmer
Vice President, Pricing & Reimbursement
RTI Health Solutions 15:50 Afternoon refreshments 16:10 China: Portfolio, Pricing & Market Access
• Portfolio optimization: Multinational Acclimation
• Pricing: Draconian Dragons
• Market Access: Guanxi Reimbursement Cyrus Chowdhury
Management Consultant
Insight Strategy Advisors 16:50 Analyzing the future pricing trends in US
• Obamamania, will it effect the development of the P&R system in the US
• Cost-effectiveness in assessing pharma products, will the US adopt such a system in line with spiralling healthcare costs
• Will the US continue to be a lucrative country for headline pricing trends, where next?
Panel members will be drawn from the speakers who take part on day one or day two. If you would like to submit a question to the panel, please email it to: pranita.nangia@visiongainglobal.com Panellists: Dr. Nick Poulios, VP-Pricing & Reimbursement Strategy, Patient Access & Public Policy, Elan Pharmaceuticals
Dr. Kevin W. Mayo, Vice President, Bridgehead International, Professor, University of the Sciences in Philadelphia
Senior Representative, IMS 17:30 Closing remarks from the chair 17:35 Networking drinks reception
Take your discussions further and build new relationships in a relaxed and informal setting Day 2 Day 2, Friday 12th June 2009 09:30 Registration and refreshments 10:00 Opening address from the chair Dr. Elyce A. Biddle
Senior Research Economist
National Institute for Occupational Safety and Health, U.S Govt. 10:10 How to maximize return on investment?
• All about ROI:
- What metrics are appropriate?
- How do you actually analyse your ROI?
• How do you ensure that your P&R strategy is genuinely and consistently creating value?
• How will broader market and policy changes affect the measurement of ROI? George Wyatt
Managing Director
Wyatt Health Management 10:50 Presentation to be announced Alina Ciobanu
Manager, Health Economics & Patient Access
Astrazeneca 11:30 Morning refreshments 11:50 Strategy to implementation: Patients receive treatment choice
• Show how health economics was used to increase reimbursement for therapy access
• Demonstrate the need for collaboration between and within organizations for achieving target results
• Discuss importance of communication strategy and execution plays a significant role in healthcare policy changes Samir K. Bhattacharyya
Senior Director Global Marketing Home Hemodialysis Therapy
Baxter Healthcare 12:30 Assessment of trends in generic pricing in US
• Pricing methods for generic medicines, what is the state of the art?
• Countering generic medicines pricing; tools and tactics
• Trends in generic pricing specific to the US, in what direction is this going? William Haddad
CEO
Biogenerics 13:10 Networking lunch 14:10 Key global pricing and reimbursement approaches
• Making a global play: is there a P&R strategy that is effective everywhere?
• Can the development of a globally-focused strategy actually contribute to P&R harmonisation?
• The importance of the product and evolving product trends to the feasibility of a global strategy Senior Principal Pricing & Market Access
IMS Consulting 14:40 Measuring the value of reducing the risk of occupational injury or illness on the firm
• Reducing or eliminating hazards to protect employees can reduce costs and increase production
• Value is found by reducing costs and increasing production, as well as accomplishing other business objectives
• The specific financial benefits of reducing risk may be found throughout a business process, and can be substantial
• Risk reduction may enable the achievement of non-financial benefits that have an indirect relationship to cost and production Dr. Elyce A. Biddle
Senior Research Economist
National Institute for Occupational Safety and Health, U.S Govt. Dee Woodhull
CIH, CSP Senior Consultant
ORC Worldwide 15:20 Pricing & reimbursement and market access strategies for new oncology products
• Current global pricing & reimbursement landscape for new oncologic agents
• Future trends and challenges in P&R for oncology products
• Lifecycle P&R issues associated with oncology drugs
• Developing successful international P&R strategies for oncologic agents
• Risk-sharing for pharmaceuticals in the US and EU Christian Schuler
Partner
Simon-Kucher & Partners 16:00 Afternoon refreshments 16:20 The ultimate patient access: keeping the patient off the illness curve Dr. Nick Poulios
VP-Pricing & Reimbursement Strategy, Patient Access & Public Policy
Elan Pharmaceuticals 17:00 Health Economics and its contribution to effective and sustainable P&R strategies
• The ever more important contribution of Health economics and Outcomes research as a key component of P&R strategies
• Taking the lead on health economics to get ahead of restrictive regulation and regional idiosyncrasies
• Expected evolution or maybe the revolution offered by health economics and outcomes research, a critical assessment Dr. Kevin W. Mayo
Vice President
Bridgehead International
Professor for Mayes College of HealthCare Business and Policy (University of the Sciences in Philadelphia) 17:30 Chair's closing remarks 17:40 End of conference
Partners
Platinum Sponsor: IMS Health
Operating in more than 100 countries, IMS Health is the world's leading provider of market intelligence to the pharmaceutical and healthcare industries. With $2.2 billion in 2007 revenue and more than 50 years of industry experience, IMS offers leading-edge market intelligence products and services that are integral to clients' day-to-day operations, including portfolio optimization capabilities; launch and brand management solutions; sales force effectiveness innovations; managed care and consumer health offerings; and consulting and services solutions that improve ROI and the delivery of quality healthcare worldwide. For further information please visit: www.imshealth.com Media Partners: PharmiWeb.com
PharmiWeb.com is the leading industry-sponsored portal for the pharmaceutical sector. Supported by most of the leading pharmaceutical corporations, PharmiWeb.com provides dynamic real-time news, features, events listings and international jobs to industry professionals across Europe and the US. For further information please email: corporate@pharmiweb.com BIOTECHNOLOGY EUROPE
BIOTECHNOLOGY EUROPE is owned by BIOTECHNOLOGY WORLD. It is based and located in Warsaw, Poland. Biotechnology World was founded in 2007 to provide the world's biotech and pharma information and market to make it universally accessible and useful for scientific and business processes. Its first step to fulfilling that mission was building the BIOTECHNOLOGY EUROPE platform that will allow a quick spread of information in different channels. BIOTECHNOLOGY EUROPE offers companies completed internet public relations, publication and marketing solutions. One of the main goals of BIOTECHNOLOGY EUROPE is to integrate the Biotech and Pharma Sector in Europe to global biotechnology, pharmaceutical and life science activities. For further information please visit www.biotechnology-europe.com Future Pharmaceuticals
Future Pharmaceuticals has forged powerful relationships with key industry leaders to provide a platform for successful brand recognition, and for senior decision-makers to have the means to procure and plan implementation strategies based on the topics covered. Positioned to be an authoritative resource within top pharma companies as well as small, specialty, and biotech, Future Pharmaceuticals magazine is geared to create a deep penetration into a highly targeted and responsive audience, bridging the gap between the industries' top issues and the solutions top-tier vendors can provide. For further information, please visit www.futurepharmaus.com InPharm
InPharm is the online platform for exclusive pharmaceutical news, comment, contracts, services, jobs and events and is home to InPharmjobs.com, Pharmafile and Pharmafocus. For further information please visit: www.In-Pharm.com Applied Management Consultants Ltd.
Applied Management Consultants Ltd. is an employee-owned and managed Canadian health care consulting firm practicing in the areas of health policy, strategic planning, drug insurance programs, health economics and program evaluation.
Current services include:
• End-to-end consulting and analytics required for securing public and private sector reimbursement
• Market access planning;
• Health and pharmacoeconomic analyses;
• Policy analysis and development;
• Health information; and
• Program evaluation and operations analysis
We sell extensive datasets and models on coverage and payer dynamics in the Canadian marketplace. Our consultants, analysts and associates are recognized experts in reimbursement and payer analytics. For further information, please visit www.appliedmanagement.ca If you would like more information on the range of sponsorship or exhibition possibilities for this conference, please contact:
Patricia Gallegos, +44 (0)20 7549 9952
patricia.gallegos@visiongainglobal.com
How to Order We have two available payment options. You can choose to pay by invoice, or alternatively by credit card, your place will be confirmed once we have processed your payment: Details required: -Company Name – -Name of user - -Email Address of user - -Users' Job Title- -Postal Address - -Contact Telephone Number - -Fax Number - -EEC VAT number (if applicable)-
Additional details for Credit Card payments
-Type of card - -Card number - -Expiry date - -Issue number (if applicable) - -Security number (3 digits, or 4 digits for Amex cards) - All details may be provided by replying to this email, on phone or sent through fax.
Who we are: Visiongain is an independent business information provider for the Telecoms, Pharmaceutical and Defence industries. We organise conferences, publish reports and newsletters, and provide consultancy services. Established in 1999, we have built a strong reputation for covering business-critical topics and investigating issues that other information providers will not. We are completely independent, we are not associated with any parent organisation or with the subjects of any of our analysis, and we are not led by PR firms or advertisers. We look forward to working with you. If you have any questions, please contact us. Unsubscribe:
As a valued contact or customer of Visiongain, you are receiving this email with information that we believe will be relevant to you. If, however, you do not wish to receive future messages, please reply to this message, typing 'unsubscribe' in the subject box of your email.
We support responsible and ethical email marketing practices. Please know that we respect your right to be purged from this marketing campaign.
Please allow 48 hours to remove your email address. Thank you for your cooperation.
Click here to Unsubscribe Terms and Conditions for management reports
By replying to this e-mail submitting your order for this product you have agreed without limitation or qualification to be bound by and to comply with these Terms and Conditions. You agree that you will not fail to complete any transaction after submitting an order to purchase a product or submit any order to purchase a product where you do not intend to complete the transaction.
Management Reports will only be sent on receipt of payment.
Terms & Conditions for conferences
NB - Due to high demand, we do not 'reserve' or 'hold' places - a request for an invoice to be raised will be treated as an official booking and will be subject to the cancellation policy as outlined below. Cancellations/substitutions and name changes: All bookings carry a 50% liability after the booking has been made, by post fax, email or web. There will be no refunds for cancellations received on or after one month before the start of the conference (e.g. cancellation on or after 20th January for a conference starting on 20th February). If you decide to cancel after this date the full invoice remains payable.
Conference notes, which are available on the day, will be sent to you.
Unfortunately we are not able to transfer places between conferences and executive briefings. However if you are unable to attend the event you may make a substitution/name change at any time as long as we are informed in writing by e-mail, fax or post. Name changes and substitutions must be from the same company and are not transferable between companies or countries.
Indemnity: visiongain Ltd reserve the right to change the conference/executive briefing content, timing, speakers or venue without notice. The event may be postponed or cancelled due to acts of terrorism, war, extreme weather conditions, industrial action, acts of God or any event beyond the control of visiongain Ltd. If such a situation arises we will endeavour to reschedule the event. However, visiongain Ltd cannot be held responsible for any cost, damage or expenses, which may be incurred by the customer as a consequence of the event being postponed or cancelled. We therefore strongly advise all customers to take out insurance to cover the cost of the registration, travel and expenses. | 
